# Trenev Trio/Healthy Trinity for Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS) and Functional Dyspepsia

> **NCT01268618** · PHASE2,PHASE3 · TERMINATED · sponsor: **Sprim Advanced Life Sciences** · enrollment: 120 (estimated)

## Conditions studied

- IBS-D and Functional Dyspepsia

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01268618
- **Lead sponsor:** Sprim Advanced Life Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2011-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01268618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01268618, "Trenev Trio/Healthy Trinity for Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS) and Functional Dyspepsia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01268618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
